<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35383205</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Apr</Month><Day>05</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Dual-gRNA approach with limited off-target effect corrects C9ORF72 repeat expansion in vivo.</ArticleTitle><Pagination><StartPage>5672</StartPage><MedlinePgn>5672</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">5672</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-022-07746-8</ELocationID><Abstract><AbstractText>C9ORF72 GGGGCC repeat expansion is the most common genetic cause for amyotrophic lateral sclerosis and frontotemporal dementia, which generates abnormal DNA and RNA structures and produces toxic proteins. Recently, efficacy of CRISPR/Cas9-mediated editing has been proven in treatment of disease. However, DNA low complexity surrounding C9ORF72 expansion increases the off-target risks. Here we provide a dual-gRNA design outside of the low complexity region which enables us to remove the repeat DNA in a 'cutting-deletion-fusion' manner with a high fusion efficiency (50%). Our dual-gRNA design limits off-target effect and does not significantly affect C9ORF72 expression. In neurons carrying patient C9ORF72 expansion, our approach removes the repeat DNA and corrects the RNA foci in vitro and in vivo. Therefore, we conclude that our proof-of-concept design correct C9ORF72 repeat expansion, which may have potential therapeutic value for the patients.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Piao</LastName><ForeName>Xuejiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School of Medicine, Medical Science Building, Room D204, Tsinghua University, Beijing, 100084, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Life Sciences, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peking-Tsinghua Joint Center for Life Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IDG/McGovern Institute for Brain Research at Tsinghua, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Meng</LastName><ForeName>Dawei</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>School of Medicine, Medical Science Building, Room D204, Tsinghua University, Beijing, 100084, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Life Sciences, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peking-Tsinghua Joint Center for Life Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IDG/McGovern Institute for Brain Research at Tsinghua, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Xue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School of Medicine, Medical Science Building, Room D204, Tsinghua University, Beijing, 100084, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peking-Tsinghua Joint Center for Life Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IDG/McGovern Institute for Brain Research at Tsinghua, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Qiang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>School of Medicine, Medical Science Building, Room D204, Tsinghua University, Beijing, 100084, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IDG/McGovern Institute for Brain Research at Tsinghua, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Hailong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Medicine, Medical Science Building, Room D204, Tsinghua University, Beijing, 100084, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Life Sciences, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peking-Tsinghua Joint Center for Life Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IDG/McGovern Institute for Brain Research at Tsinghua, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Yichang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Medicine, Medical Science Building, Room D204, Tsinghua University, Beijing, 100084, China. yichangjia@tsinghua.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peking-Tsinghua Joint Center for Life Sciences, Beijing, China. yichangjia@tsinghua.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IDG/McGovern Institute for Brain Research at Tsinghua, Beijing, China. yichangjia@tsinghua.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017394">RNA, Guide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042622" MajorTopicYN="N">DNA Repeat Expansion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017394" MajorTopicYN="N">RNA, Guide, Kinetoplastida</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>6</Day><Hour>5</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35383205</ArticleId><ArticleId IdType="pmc">PMC8983752</ArticleId><ArticleId IdType="doi">10.1038/s41598-022-07746-8</ArticleId><ArticleId IdType="pii">10.1038/s41598-022-07746-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Renton AE, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chio A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Belzil VV, et al. Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood. Acta Neuropathol. 2013;126:895&#x2013;905. doi: 10.1007/s00401-013-1199-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1199-1</ArticleId><ArticleId IdType="pmc">PMC3830740</ArticleId><ArticleId IdType="pubmed">24166615</ArticleId></ArticleIdList></Reference><Reference><Citation>Xi Z, et al. The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients. Acta Neuropathol. 2015;129:715&#x2013;727. doi: 10.1007/s00401-015-1401-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1401-8</ArticleId><ArticleId IdType="pubmed">25716178</ArticleId></ArticleIdList></Reference><Reference><Citation>Xi Z, et al. Hypermethylation of the CpG island near the G4C2 repeat in ALS with a C9orf72 expansion. Am. J. Hum. Genet. 2013;92:981&#x2013;989. doi: 10.1016/j.ajhg.2013.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2013.04.017</ArticleId><ArticleId IdType="pmc">PMC3675239</ArticleId><ArticleId IdType="pubmed">23731538</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, et al. Heterochromatin anomalies and double-stranded RNA accumulation underlie C9orf72 poly(PR) toxicity. Science. 2019 doi: 10.1126/science.aav2606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav2606</ArticleId><ArticleId IdType="pmc">PMC6524780</ArticleId><ArticleId IdType="pubmed">30765536</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Rourke JG, et al. C9orf72 is required for proper macrophage and microglial function in mice. Science. 2016;351:1324&#x2013;1329. doi: 10.1126/science.aaf1064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf1064</ArticleId><ArticleId IdType="pmc">PMC5120541</ArticleId><ArticleId IdType="pubmed">26989253</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry A, et al. Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease. Sci. Transl. Med. 2016 doi: 10.1126/scitranslmed.aaf6038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaf6038</ArticleId><ArticleId IdType="pmc">PMC5024536</ArticleId><ArticleId IdType="pubmed">27412785</ArticleId></ArticleIdList></Reference><Reference><Citation>Atanasio A, et al. C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice. Sci. Rep. 2016;6:23204. doi: 10.1038/srep23204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep23204</ArticleId><ArticleId IdType="pmc">PMC4793236</ArticleId><ArticleId IdType="pubmed">26979938</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang J, et al. Gain of toxicity from ALS/FTD-linked repeat expansions in C9ORF72 is alleviated by antisense oligonucleotides targeting GGGGCC-containing RNAs. Neuron. 2016;90:535&#x2013;550. doi: 10.1016/j.neuron.2016.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.006</ArticleId><ArticleId IdType="pmc">PMC4860075</ArticleId><ArticleId IdType="pubmed">27112497</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan PM, et al. The ALS/FTLD associated protein C9orf72 associates with SMCR8 and WDR41 to regulate the autophagy-lysosome pathway. Acta Neuropathol. Commun. 2016;4:51. doi: 10.1186/s40478-016-0324-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0324-5</ArticleId><ArticleId IdType="pmc">PMC4870812</ArticleId><ArticleId IdType="pubmed">27193190</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitler AD, Tsuiji H. There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS. Brain Res. 2016;1647:19&#x2013;29. doi: 10.1016/j.brainres.2016.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.04.004</ArticleId><ArticleId IdType="pmc">PMC5003651</ArticleId><ArticleId IdType="pubmed">27059391</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R, Isaacs AM. C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat. Rev. Neurol. 2018;14:544&#x2013;558. doi: 10.1038/s41582-018-0047-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J, et al. Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions. Brain. 2014;137:2040&#x2013;2051. doi: 10.1093/brain/awu120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu120</ArticleId><ArticleId IdType="pmc">PMC4065024</ArticleId><ArticleId IdType="pubmed">24866055</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YB, et al. Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic. Cell Rep. 2013;5:1178&#x2013;1186. doi: 10.1016/j.celrep.2013.10.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.10.049</ArticleId><ArticleId IdType="pmc">PMC3898469</ArticleId><ArticleId IdType="pubmed">24290757</ArticleId></ArticleIdList></Reference><Reference><Citation>Sareen D, et al. Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci. Transl. Med. 2013 doi: 10.1126/scitranslmed.3007529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3007529</ArticleId><ArticleId IdType="pmc">PMC4090945</ArticleId><ArticleId IdType="pubmed">24154603</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly CJ, et al. RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron. 2013;80:415&#x2013;428. doi: 10.1016/j.neuron.2013.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.10.015</ArticleId><ArticleId IdType="pmc">PMC4098943</ArticleId><ArticleId IdType="pubmed">24139042</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon EG, et al. The C9ORF72 GGGGCC expansion forms RNA G-quadruplex inclusions and sequesters hnRNP H to disrupt splicing in ALS brains. Elife. 2016 doi: 10.7554/eLife.17820.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.17820</ArticleId><ArticleId IdType="pmc">PMC5050020</ArticleId><ArticleId IdType="pubmed">27623008</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, et al. hnRNP A3 binds to GGGGCC repeats and is a constituent of p62-positive/TDP43-negative inclusions in the hippocampus of patients with C9orf72 mutations. Acta Neuropathol. 2013;125:413&#x2013;423. doi: 10.1007/s00401-013-1088-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1088-7</ArticleId><ArticleId IdType="pubmed">23381195</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash PE, et al. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron. 2013;77:639&#x2013;646. doi: 10.1016/j.neuron.2013.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.02.004</ArticleId><ArticleId IdType="pmc">PMC3593233</ArticleId><ArticleId IdType="pubmed">23415312</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, et al. Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. Acta Neuropathol. 2013;126:881&#x2013;893. doi: 10.1007/s00401-013-1189-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1189-3</ArticleId><ArticleId IdType="pubmed">24132570</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, et al. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science. 2013;339:1335&#x2013;1338. doi: 10.1126/science.1232927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1232927</ArticleId><ArticleId IdType="pubmed">23393093</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, et al. Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathol. 2013;126:829&#x2013;844. doi: 10.1007/s00401-013-1192-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1192-8</ArticleId><ArticleId IdType="pmc">PMC3830741</ArticleId><ArticleId IdType="pubmed">24129584</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu T, et al. RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc. Natl. Acad. Sci. USA. 2013;110:E4968&#x2013;4977. doi: 10.1073/pnas.1315438110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1315438110</ArticleId><ArticleId IdType="pmc">PMC3870665</ArticleId><ArticleId IdType="pubmed">24248382</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, et al. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature. 2015;525:129&#x2013;133. doi: 10.1038/nature14974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14974</ArticleId><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, et al. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature. 2015;525:56&#x2013;61. doi: 10.1038/nature14973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14973</ArticleId><ArticleId IdType="pmc">PMC4800742</ArticleId><ArticleId IdType="pubmed">26308891</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KH, et al. C9orf72 dipeptide repeats impair the assembly, dynamics, and function of membrane-less organelles. Cell. 2016 doi: 10.1016/j.cell.2016.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.10.002</ArticleId><ArticleId IdType="pmc">PMC5079111</ArticleId><ArticleId IdType="pubmed">27768896</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, et al. Poly(GR) impairs protein translation and stress granule dynamics in C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis. Nat. Med. 2018;24:1136&#x2013;1142. doi: 10.1038/s41591-018-0071-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0071-1</ArticleId><ArticleId IdType="pmc">PMC6520050</ArticleId><ArticleId IdType="pubmed">29942091</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, et al. C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins. Nat. Neurosci. 2016;19:668&#x2013;677. doi: 10.1038/nn.4272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4272</ArticleId><ArticleId IdType="pmc">PMC5138863</ArticleId><ArticleId IdType="pubmed">26998601</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright AV, Nunez JK, Doudna JA. Biology and applications of CRISPR systems: harnessing nature's toolbox for genome engineering. Cell. 2016;164:29&#x2013;44. doi: 10.1016/j.cell.2015.12.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.12.035</ArticleId><ArticleId IdType="pubmed">26771484</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickar-Oliver A, Gersbach CA. The next generation of CRISPR-Cas technologies and applications. Nat. Rev. Mol. Cell Biol. 2019;20:490&#x2013;507. doi: 10.1038/s41580-019-0131-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-019-0131-5</ArticleId><ArticleId IdType="pmc">PMC7079207</ArticleId><ArticleId IdType="pubmed">31147612</ArticleId></ArticleIdList></Reference><Reference><Citation>Komor AC, Badran AH, Liu DR. CRISPR-based technologies for the manipulation of eukaryotic genomes. Cell. 2017;168:20&#x2013;36. doi: 10.1016/j.cell.2016.10.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.10.044</ArticleId><ArticleId IdType="pmc">PMC5235943</ArticleId><ArticleId IdType="pubmed">27866654</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabebordbar M, et al. In vivo gene editing in dystrophic mouse muscle and muscle stem cells. Science. 2016;351:407&#x2013;411. doi: 10.1126/science.aad5177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad5177</ArticleId><ArticleId IdType="pmc">PMC4924477</ArticleId><ArticleId IdType="pubmed">26721686</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson CE, et al. In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy. Science. 2016;351:403&#x2013;407. doi: 10.1126/science.aad5143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad5143</ArticleId><ArticleId IdType="pmc">PMC4883596</ArticleId><ArticleId IdType="pubmed">26721684</ArticleId></ArticleIdList></Reference><Reference><Citation>Long C, et al. Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy. Science. 2016;351:400&#x2013;403. doi: 10.1126/science.aad5725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad5725</ArticleId><ArticleId IdType="pmc">PMC4760628</ArticleId><ArticleId IdType="pubmed">26721683</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Rourke JG, et al. C9orf72 BAC transgenic mice display typical pathologic features of ALS/FTD. Neuron. 2015;88:892&#x2013;901. doi: 10.1016/j.neuron.2015.10.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.10.027</ArticleId><ArticleId IdType="pmc">PMC4672384</ArticleId><ArticleId IdType="pubmed">26637796</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, et al. C9orf72 BAC mouse model with motor deficits and neurodegenerative features of ALS/FTD. Neuron. 2016;90:521&#x2013;534. doi: 10.1016/j.neuron.2016.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.005</ArticleId><ArticleId IdType="pubmed">27112499</ArticleId></ArticleIdList></Reference><Reference><Citation>Blainey P, Krzywinski M, Altman N. Points of significance: replication. Nat. Methods. 2014;11:879&#x2013;880. doi: 10.1038/nmeth.3091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3091</ArticleId><ArticleId IdType="pubmed">25317452</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai SQ, et al. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat. Biotechnol. 2015;33:187&#x2013;197. doi: 10.1038/nbt.3117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3117</ArticleId><ArticleId IdType="pmc">PMC4320685</ArticleId><ArticleId IdType="pubmed">25513782</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754&#x2013;1760. doi: 10.1093/bioinformatics/btp324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp324</ArticleId><ArticleId IdType="pmc">PMC2705234</ArticleId><ArticleId IdType="pubmed">19451168</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010;26:841&#x2013;842. doi: 10.1093/bioinformatics/btq033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btq033</ArticleId><ArticleId IdType="pmc">PMC2832824</ArticleId><ArticleId IdType="pubmed">20110278</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeussler M, et al. Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR. Genome Biol. 2016;17:148. doi: 10.1186/s13059-016-1012-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-016-1012-2</ArticleId><ArticleId IdType="pmc">PMC4934014</ArticleId><ArticleId IdType="pubmed">27380939</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu PD, et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 2013;31:827&#x2013;832. doi: 10.1038/nbt.2647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.2647</ArticleId><ArticleId IdType="pmc">PMC3969858</ArticleId><ArticleId IdType="pubmed">23873081</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanjana NE, Shalem O, Zhang F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods. 2014;11:783&#x2013;784. doi: 10.1038/nmeth.3047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3047</ArticleId><ArticleId IdType="pmc">PMC4486245</ArticleId><ArticleId IdType="pubmed">25075903</ArticleId></ArticleIdList></Reference><Reference><Citation>Aparicio-Prat E, et al. DECKO: Single-oligo, dual-CRISPR deletion of genomic elements including long non-coding RNAs. BMC Genom. 2015;16:846. doi: 10.1186/s12864-015-2086-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12864-015-2086-z</ArticleId><ArticleId IdType="pmc">PMC4619085</ArticleId><ArticleId IdType="pubmed">26493208</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae S, Park J, Kim JS. Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics. 2014;30:1473&#x2013;1475. doi: 10.1093/bioinformatics/btu048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btu048</ArticleId><ArticleId IdType="pmc">PMC4016707</ArticleId><ArticleId IdType="pubmed">24463181</ArticleId></ArticleIdList></Reference><Reference><Citation>Platt RJ, et al. CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014;159:440&#x2013;455. doi: 10.1016/j.cell.2014.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.09.014</ArticleId><ArticleId IdType="pmc">PMC4265475</ArticleId><ArticleId IdType="pubmed">25263330</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, et al. Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Proc. Natl. Acad. Sci. USA. 2013;110:E4530&#x2013;4539. doi: 10.1073/pnas.1318835110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1318835110</ArticleId><ArticleId IdType="pmc">PMC3839752</ArticleId><ArticleId IdType="pubmed">24170860</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters OM, et al. Human C9ORF72 hexanucleotide expansion reproduces RNA foci and dipeptide repeat proteins but not neurodegeneration in BAC transgenic mice. Neuron. 2015;88:902&#x2013;909. doi: 10.1016/j.neuron.2015.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.11.018</ArticleId><ArticleId IdType="pmc">PMC4828340</ArticleId><ArticleId IdType="pubmed">26637797</ArticleId></ArticleIdList></Reference><Reference><Citation>Batra R, et al. Elimination of toxic microsatellite repeat expansion RNA by RNA-targeting Cas9. Cell. 2017 doi: 10.1016/j.cell.2017.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.07.010</ArticleId><ArticleId IdType="pmc">PMC5873302</ArticleId><ArticleId IdType="pubmed">28803727</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto BS, et al. Impeding transcription of expanded microsatellite repeats by deactivated Cas9. Mol. Cell. 2017 doi: 10.1016/j.molcel.2017.09.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2017.09.033</ArticleId><ArticleId IdType="pmc">PMC6013302</ArticleId><ArticleId IdType="pubmed">29056323</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer NJ, et al. Spt4 selectively regulates the expression of C9orf72 sense and antisense mutant transcripts. Science. 2016;353:708&#x2013;712. doi: 10.1126/science.aaf7791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf7791</ArticleId><ArticleId IdType="pmc">PMC5823025</ArticleId><ArticleId IdType="pubmed">27516603</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R, et al. Partial inhibition of the overactivated Ku80-dependent DNA repair pathway rescues neurodegeneration in C9ORF72-ALS/FTD. Proc Natl Acad Sci USA. 2019;116:9628&#x2013;9633. doi: 10.1073/pnas.1901313116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1901313116</ArticleId><ArticleId IdType="pmc">PMC6511021</ArticleId><ArticleId IdType="pubmed">31019093</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade NS, et al. Dipeptide repeat proteins inhibit homology-directed DNA double strand break repair in C9ORF72 ALS/FTD. Mol. Neurodegener. 2020;15:13. doi: 10.1186/s13024-020-00365-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00365-9</ArticleId><ArticleId IdType="pmc">PMC7041170</ArticleId><ArticleId IdType="pubmed">32093728</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvaraj BT, et al. C9ORF72 repeat expansion causes vulnerability of motor neurons to Ca(2+)-permeable AMPA receptor-mediated excitotoxicity. Nat. Commun. 2018;9:347. doi: 10.1038/s41467-017-02729-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02729-0</ArticleId><ArticleId IdType="pmc">PMC5783946</ArticleId><ArticleId IdType="pubmed">29367641</ArticleId></ArticleIdList></Reference><Reference><Citation>Akcakaya P, et al. In vivo CRISPR editing with no detectable genome-wide off-target mutations. Nature. 2018;561:416&#x2013;419. doi: 10.1038/s41586-018-0500-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0500-9</ArticleId><ArticleId IdType="pmc">PMC6194229</ArticleId><ArticleId IdType="pubmed">30209390</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleinstiver BP, et al. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. Nature. 2016;529:490&#x2013;495. doi: 10.1038/nature16526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature16526</ArticleId><ArticleId IdType="pmc">PMC4851738</ArticleId><ArticleId IdType="pubmed">26735016</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai SQ, et al. CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR-Cas9 nuclease off-targets. Nat Methods. 2017;14:607&#x2013;614. doi: 10.1038/nmeth.4278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.4278</ArticleId><ArticleId IdType="pmc">PMC5924695</ArticleId><ArticleId IdType="pubmed">28459458</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JS, et al. Enhanced proofreading governs CRISPR-Cas9 targeting accuracy. Nature. 2017;550:407&#x2013;410. doi: 10.1038/nature24268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature24268</ArticleId><ArticleId IdType="pmc">PMC5918688</ArticleId><ArticleId IdType="pubmed">28931002</ArticleId></ArticleIdList></Reference><Reference><Citation>Martier R, et al. Artificial MicroRNAs targeting C9orf72 can reduce accumulation of intra-nuclear transcripts in ALS and FTD patients. Mol. Ther. Nucl. Acids. 2019;14:593&#x2013;608. doi: 10.1016/j.omtn.2019.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2019.01.010</ArticleId><ArticleId IdType="pmc">PMC6378669</ArticleId><ArticleId IdType="pubmed">30776581</ArticleId></ArticleIdList></Reference><Reference><Citation>Ran FA, et al. In vivo genome editing using Staphylococcus aureus Cas9. Nature. 2015;520:186&#x2013;191. doi: 10.1038/nature14299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14299</ArticleId><ArticleId IdType="pmc">PMC4393360</ArticleId><ArticleId IdType="pubmed">25830891</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedland AE, et al. Characterization of Staphylococcus aureus Cas9: a smaller Cas9 for all-in-one adeno-associated virus delivery and paired nickase applications. Genome Biol. 2015;16:257. doi: 10.1186/s13059-015-0817-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-015-0817-8</ArticleId><ArticleId IdType="pmc">PMC4657203</ArticleId><ArticleId IdType="pubmed">26596280</ArticleId></ArticleIdList></Reference><Reference><Citation>Bengtsson NE, et al. Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy. Nat. Commun. 2017;8:14454. doi: 10.1038/ncomms14454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms14454</ArticleId><ArticleId IdType="pmc">PMC5316861</ArticleId><ArticleId IdType="pubmed">28195574</ArticleId></ArticleIdList></Reference><Reference><Citation>Min YL, et al. CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells. Sci. Adv. 2019 doi: 10.1126/sciadv.aav4324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aav4324</ArticleId><ArticleId IdType="pmc">PMC6402849</ArticleId><ArticleId IdType="pubmed">30854433</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo E, et al. One-step generation of complete gene knockout mice and monkeys by CRISPR/Cas9-mediated gene editing with multiple sgRNAs. Cell Res. 2017;27:933&#x2013;945. doi: 10.1038/cr.2017.81.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2017.81</ArticleId><ArticleId IdType="pmc">PMC5518993</ArticleId><ArticleId IdType="pubmed">28585534</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S, et al. CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington's disease. J. Clin. Invest. 2017;127:2719&#x2013;2724. doi: 10.1172/JCI92087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI92087</ArticleId><ArticleId IdType="pmc">PMC5490741</ArticleId><ArticleId IdType="pubmed">28628038</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao X, et al. Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents. Nature. 2018;553:217&#x2013;221. doi: 10.1038/nature25164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature25164</ArticleId><ArticleId IdType="pmc">PMC5784267</ArticleId><ArticleId IdType="pubmed">29258297</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Tai PWL, Gao G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat. Rev. Drug Discov. 2019;18:358&#x2013;378. doi: 10.1038/s41573-019-0012-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-019-0012-9</ArticleId><ArticleId IdType="pmc">PMC6927556</ArticleId><ArticleId IdType="pubmed">30710128</ArticleId></ArticleIdList></Reference><Reference><Citation>Lord SJ, Velle KB, Mullins RD, Fritz-Laylin LK. SuperPlots: communicating reproducibility and variability in cell biology. J. Cell Biol. 2020 doi: 10.1083/jcb.202001064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.202001064</ArticleId><ArticleId IdType="pmc">PMC7265319</ArticleId><ArticleId IdType="pubmed">32346721</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>